Dow Jones

40 003,59

0,34%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Q BioMed Inc (CE) (QBIO)
Q BioMed Inc (CE) (QBIO) Actualités

QBIO

Q BioMed (CE) (QBIO)

Q BioMed Inc (CE)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:QBIO

Date	Heure	Source	Titre	Symbole	Société
16/06/2023	22h01	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:QBIO	Q BioMed Inc (CE)
26/05/2023	22h56	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:QBIO	Q BioMed Inc (CE)
01/03/2023	19h02	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:QBIO	Q BioMed Inc (CE)
07/12/2022	21h01	Edgar (US Regulatory)	Information Statement - All Other (definitive) (def 14c)	USOTC:QBIO	Q BioMed Inc (CE)
18/11/2022	23h16	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:QBIO	Q BioMed Inc (CE)
15/07/2022	23h01	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:QBIO	Q BioMed Inc (CE)
11/01/2022	22h36	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:QBIO	Q BioMed Inc (CE)
26/02/2021	18h52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:QBIO	Q BioMed Inc (CE)
11/01/2021	12h01	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:QBIO	Q BioMed Inc (CE)
15/09/2020	14h53	InvestorsHub NewsWire	Q BioMed Announces Strontium89 Initial Uptake and Momentum in US and Europe	USOTC:QBIO	Q BioMed Inc (CE)
26/08/2020	13h30	InvestorsHub NewsWire	Q BioMed Announces Initiation of GMP Production of Novel COVID-19 Therapeutic for Clinical Trial Program	USOTC:QBIO	Q BioMed Inc (CE)
11/08/2020	14h05	InvestorsHub NewsWire	Q BioMed Announces Strontium89 will be available as of September 2020 through Named Patient Program for Bone Metastases Pain	USOTC:QBIO	Q BioMed Inc (CE)
11/06/2020	18h13	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:QBIO	Q BioMed Inc (CE)
21/05/2020	19h51	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:QBIO	Q BioMed Inc (CE)
11/05/2020	12h00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:QBIO	Q BioMed Inc (CE)
19/03/2020	21h26	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:QBIO	Q BioMed Inc (CE)
16/12/2019	21h08	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:QBIO	Q BioMed Inc (CE)
06/09/2019	20h16	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:QBIO	Q BioMed Inc (CE)
19/03/2019	16h20	InvestorsHub NewsWire	GDET CEO Interviewed By Goldman Small Cap Research On New Cannabis Business	USOTC:QBIO	Q BioMed Inc (CE)
13/12/2018	21h25	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:QBIO	Q BioMed Inc (CE)
06/12/2018	20h51	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	USOTC:QBIO	Q BioMed Inc (CE)
19/10/2018	16h47	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	USOTC:QBIO	Q BioMed Inc (CE)
08/06/2018	17h54	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	USOTC:QBIO	Q BioMed Inc (CE)
26/02/2018	21h23	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:QBIO	Q BioMed Inc (CE)
04/10/2017	23h08	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	USOTC:QBIO	Q BioMed Inc (CE)
10/03/2017	22h10	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	USOTC:QBIO	Q BioMed Inc (CE)
27/07/2016	15h00	InvestorsHub NewsWire	Four Trending Stocks Leading Biotech Sector on Heels of Latest R&D and Innovative Drug Therapy Advancements	USOTC:QBIO	Q BioMed Inc (CE)
30/10/2015	13h21	Edgar (US Regulatory)	Securities Registration (section 12(g)) (8-a12g)	USOTC:QBIO	Q BioMed Inc (CE)